Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Short course of hCG may have chemoprotective potential
March 24th, 2005
Researchers at Philadelphia's Fox Chase Cancer Center suggest that a short course of human chorionic gonadotropin (hCG) may have a protective effect against breast cancer. "Sporadic breast cancer is a fatal disease most frequently diagnosed in American women from all ethnic groups, suggesting that primary prevention should be the ultimate goal for breast cancer control. We have developed a novel paradigm for breast cancer prevention arising from the well-established knowledge that an early first full-term pregnancy protects the breast against neoplastic transformation, as well as from our studies of the biological principle underlying this protection," reported J. Russo...
Source: Women's Health Weekly (2005-03-24)
|
